Arkolith/Insider Trading/CRNX/Form 4

Pizzuti Dana

Chief Med and Dev OfficerCrinetics Pharmaceuticals, Inc. (CRNX) · full profile →Form 4 · filed Aug 26, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$913K
Net Open-Market Flow
-$913K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 22, 2025Option exercise(M)30K$16.89$507K96K
Aug 22, 2025Sell(S)30K$30.43$913K66K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 22, 2025Option exercise(M)30K—$089K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001948238-25-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML